To investigate the effects of direct DYRK1A knockdown in the brain on Aβ pathology in a mouse model of early phase AD, 3.5-month-old 5xFAD mice were injected with AAV-control shRNA or AAV-DYRK1A shRNA in the hippocampus. Here, DYRK1A is linked to Alzheimer disease.